Comments on: Grassley: Review Antipsychotics In Nursing Homes

By: Jobs From Homes

Jobs From Homes — Sat, 01 Mar 2008 20:36:39 +0000

How to become an internet Millionaire in the Self-Improvement Industry working from Home…

With the challenges and pressures that exist with today’s life style, the self-improvement and self-help industry is booming….

By: Big Pharma Employee

Big Pharma Employee — Thu, 27 Dec 2007 18:03:07 +0000

Most unfortunately, much of the prescribing can be linked to those CME programs identifying the appropriate teenage patient for antispychotics. All health care providers are aware that ADHD and bipolar disease are very difficult to distinguish even for the most seasoned psychiatrists. Those company sponsored speaker programs could also contribute to the upswing in off label usage of atypical antipsychotics as well.

By: sid

sid — Fri, 07 Dec 2007 01:39:49 +0000

anyone heard of consultant pharmacists? How about the newly updated State Operations Manual?

If the answer to those questions is no, please step over to Sen Grassley’s side of the room. This has been something that has been done since OBRA 1992.

But great for me — please Sen Grassley and all of the wise politicians demand greater oversight and even more regulations. You see I am a consultant and anything that creates more work creates more demand. That increases my value and paycheck and actually likely increases cost of care. But hey, anymore money in my pocket instead of the gov’t is fine with this guy.

By: Ed

Ed — Thu, 06 Dec 2007 22:00:38 +0000

Maybe Senator McCaskill of MO can shed some light on the subject, since her husband has made a fortune running nursing homes.

By: Lisa Van S

Lisa Van S — Thu, 06 Dec 2007 21:38:06 +0000

Way to go Chuck!!…
We also need an Investigation into the Prescibing of these nasty drugs to Infants and Toddlers….

By: Dan

Dan — Thu, 06 Dec 2007 21:09:02 +0000

Senator Grassley and others should attempt to discover as to whether or not the prescribers of these meds were or are incentivized by the makers of such drugs that are prescribed to these patients.